Oncolytics Biotech Inc. Share Price & Technical Analysis
ONCY · $0.82 (+1.23%)
Healthcare / Biotechnology
$0.82
+1.23%
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (GI) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Ho…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
-11% return in May, -14% avg return in past 3 year May month.
-8% return in 2026, 23% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 11% | 10% | -18% | 0% | -11% | – | – | – | – | – | – | – | -8% |
| 25 | -22% | 0% | -14% | 20% | -50% | 167% | 25% | 0% | 40% | -14% | -17% | -10% | 124% |
| 24 | -14% | -8% | -8% | 0% | 0% | -9% | 0% | 0% | -10% | 22% | -25% | 0% | -53% |
| 23 | 13% | -17% | -20% | 25% | 7% | 53% | -4% | -8% | -8% | -23% | -12% | -7% | -1% |
| 22 | 36% | -15% | -6% | -19% | -8% | -17% | 10% | 27% | -14% | 8% | 50% | -16% | 37% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (GI) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$103.78M
P/E ratio
—
52W high
$1.51
52W low
$0.33
Volume
3,45,976
Beta
1.03
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Oncolytics Biotech Inc. share price today?
- Oncolytics Biotech Inc. (ONCY) last traded around $0.82 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ONCY have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ONCY. Download the app for real-time alerts.
- How can I analyze Oncolytics Biotech Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.